Previous 10 | Next 10 |
VolitionRx Limited Schedules Second Quarter 2021 Earnings Conference Call and Business Update Conference call to take place Thursday, August 12, 2021 at 8:00 am Eastern time PR Newswire AUSTIN, Texas , Aug. 4, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AME...
Volition's Nu.Q® NETs Assay Demonstrates Promising Results in COVID-19 Risk Stratification and Disease Monitoring PR Newswire AUSTIN, Texas , July 22, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics co...
NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the June 24 th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcased live company presentations and inte...
VolitionRx is now a commercial concern with the beta launch of its dog cancer blood tests in Texas commencing 4Q20. The company’s unique epigenetic approach to testing has the potential to detect cancer earlier and should have applications in many other disease types. With ...
Presentation Times and Weblinks Released for Approximately 70 Presenting Companies Wednesday and Thursday, June 23-24, 2021 NEW YORK, NY / ACCESSWIRE / June 22, 2021 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day Summer Virtual Small...
AUSTIN, Texas, June 21, 2021 (GLOBE NEWSWIRE) -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, today an...
NEW YORK, June 21, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and ...
May 19 - 20, 2021 Presentation times and weblinks released for over 60 presenting companies NEW YORK, NY / ACCESSWIRE / May 18, 2021 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day spring Microcap Virtual Conference taking place Wedne...
VolitionRx Ltd. (NYSE American: VNRX) is a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potential to not only prolong the life of patients, but also to improve the...
Image source: The Motley Fool. Volition Rx Limited (NYSEMKT: VNRX) Q1 2021 Earnings Call May 12, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Volition Rx Limited (VNRX) Q1 2021 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
VolitionRx Limited (NYSE American: VNRX) , a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, announced the engagement of PharmaVentures Ltd (“PharmaVentures”) to act as an advisor. PharmaVentures w...
Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensing PR Newswire HENDERSON, Nev. , July 9, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has appointed PharmaV...
VolitionRx Limited (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, has released a mid-year review that highlights significant milestones, such as the expansio...